Intuitive's sales and profits exceeded expectations, but a warning about Trump's import tax proposal may have worried ...
Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).
RevMedica announced that the FDA accepted its Endo stapling platform into its Safer Technologies Program (STeP).
A federal judge rejected Intuitive's request to end an antitrust trial. The case involves third-party servicing of robotic surgery tools.